Free Trial

InMode (INMD) Stock Price, News & Analysis

InMode logo
$14.96 +0.04 (+0.23%)
As of 10:09 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About InMode Stock (NASDAQ:INMD)

Key Stats

Today's Range
$14.85
$15.00
50-Day Range
$13.28
$15.36
52-Week Range
$13.14
$19.85
Volume
28,469 shs
Average Volume
1.26 million shs
Market Capitalization
$945.31 million
P/E Ratio
6.06
Dividend Yield
N/A
Price Target
$18.04
Consensus Rating
Hold

Company Overview

InMode Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

INMD MarketRank™: 

InMode scored higher than 45% of companies evaluated by MarketBeat, and ranked 588th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InMode has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 1 buy rating, 7 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    InMode has only been the subject of 3 research reports in the past 90 days.

  • Read more about InMode's stock forecast and price target.
  • Earnings Growth

    Earnings for InMode are expected to grow by 4.00% in the coming year, from $1.75 to $1.82 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InMode is 6.06, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.78.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InMode is 6.06, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.27.

  • Price to Book Value per Share Ratio

    InMode has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about InMode's valuation and earnings.
  • Percentage of Shares Shorted

    5.83% of the float of InMode has been sold short.
  • Short Interest Ratio / Days to Cover

    InMode has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InMode has recently increased by 3.63%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    InMode does not currently pay a dividend.

  • Dividend Growth

    InMode does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.83% of the float of InMode has been sold short.
  • Short Interest Ratio / Days to Cover

    InMode has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InMode has recently increased by 3.63%, indicating that investor sentiment is decreasing.
  • News Sentiment

    InMode has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for InMode this week, compared to 5 articles on an average week.
  • Search Interest

    Only 3 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added InMode to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InMode insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.92% of the stock of InMode is held by insiders.

  • Percentage Held by Institutions

    68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InMode's insider trading history.
Receive INMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INMD Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
InMode’s Earnings Call: Balancing Growth and Challenges
InMode (INMD) Gets a Hold from Canaccord Genuity
What To Expect From InMode Ltd (INMD) Q2 2025 Earnings
See More Headlines

INMD Stock Analysis - Frequently Asked Questions

InMode's stock was trading at $16.70 at the beginning of the year. Since then, INMD stock has decreased by 10.3% and is now trading at $14.98.

InMode Ltd. (NASDAQ:INMD) released its quarterly earnings results on Wednesday, July, 30th. The healthcare company reported $0.47 EPS for the quarter, missing analysts' consensus estimates of $0.50 by $0.03. The firm's quarterly revenue was up 10.6% compared to the same quarter last year.
Read the conference call transcript
.

Shares of InMode split on Thursday, September 30th 2021.The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were issued to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

InMode subsidiaries include Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..

InMode (INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager.

InMode's top institutional investors include LSV Asset Management (3.07%), Meitav Investment House Ltd. (2.09%), Boston Trust Walden Corp (2.09%) and Systematic Financial Management LP (1.73%).

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/30/2025
Today
8/28/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:INMD
CIK
1742692
Fax
N/A
Employees
480
Year Founded
2008

Price Target and Rating

High Price Target
$25.00
Low Price Target
$15.00
Potential Upside/Downside
+20.9%
Consensus Rating
Hold
Rating Score (0-4)
2.13
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.47
Trailing P/E Ratio
6.04
Forward P/E Ratio
8.53
P/E Growth
N/A
Net Income
$181.27 million
Net Margins
44.50%
Pretax Margin
35.81%
Return on Equity
18.38%
Return on Assets
16.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.60
Quick Ratio
8.58

Sales & Book Value

Annual Sales
$394.82 million
Price / Sales
2.39
Cash Flow
$1.79 per share
Price / Cash Flow
8.33
Book Value
$9.94 per share
Price / Book
1.50

Miscellaneous

Outstanding Shares
63,210,000
Free Float
58,835,000
Market Cap
$943.09 million
Optionable
Optionable
Beta
1.93

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:INMD) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners